The type, size and duration of vaccination zones I and II listed in Annex II to Implementing Decision (EU) 2025/2248 need to be amended in the light of the evolving epidemiological situation as regards infection with lumpy skin disease virus, and the progress of the vaccination campaign, particularly taking into account the evolving level of vaccine coverage achieved. Accordingly, it is necessary to indicate, in Annex II to that Implementing Decision, the dates for the duration of the vaccination zones I and II.
Recital 8, Decision_act (EU) 2026/230
In forcesince 26 Jan 2026